Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Long-Term Deferred Tax (2016 - 2024)

Historic Long-Term Deferred Tax for Surgery Partners (SGRY) over the last 10 years, with Q3 2024 value amounting to $79.2 million.

  • Surgery Partners' Long-Term Deferred Tax fell 2457.14% to $79.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $79.2 million, marking a year-over-year decrease of 2457.14%. This contributed to the annual value of $89.5 million for FY2023, which is 218.58% down from last year.
  • Per Surgery Partners' latest filing, its Long-Term Deferred Tax stood at $79.2 million for Q3 2024, which was down 2457.14% from $81.8 million recorded in Q2 2024.
  • Over the past 5 years, Surgery Partners' Long-Term Deferred Tax peaked at $129.8 million during Q2 2021, and registered a low of $79.2 million during Q3 2024.
  • In the last 5 years, Surgery Partners' Long-Term Deferred Tax had a median value of $105.7 million in 2023 and averaged $106.3 million.
  • As far as peak fluctuations go, Surgery Partners' Long-Term Deferred Tax surged by 2644.38% in 2020, and later plummeted by 2457.14% in 2024.
  • Over the past 5 years, Surgery Partners' Long-Term Deferred Tax (Quarter) stood at $124.8 million in 2020, then fell by 8.33% to $114.4 million in 2021, then dropped by 20.02% to $91.5 million in 2022, then fell by 2.19% to $89.5 million in 2023, then dropped by 11.51% to $79.2 million in 2024.
  • Its last three reported values are $79.2 million in Q3 2024, $81.8 million for Q2 2024, and $87.0 million during Q1 2024.